140 completed, 39 unknown, 18 recruiting, 9 active not recruiting. 63 Phase 2, 60 Phase 3, 49 Not applicable, 21 Phase 1, 15 Phase 4.
Follow this condition Literature Review of Warts trials Research Report on Warts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart | Phase 2 | Suspended | G&E Herbal Biotechnology Co., LTD | 102 | 2030-09-01 | 2023-09-14 |
| Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM Busulfan, Palifermin, Plerixafor - WHIM, Warts | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2026-10-26 | 2026-10-21 |
| Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts Intralesional Acyclovir, Intralesional Zinc Sulphate - Warts, Plantar Warts | Phase 3 | Not yet recruiting | Assiut University | 76 | 2026-10-01 | 2026-09-29 |
| Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5) VP-102 - Common Warts, Common Warts (Verruca Vulgaris) | Phase 2 | Not yet recruiting | Verrica Pharmaceuticals Inc. | 30 | 2026-10-01 | 2026-10-20 |
| Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel Geniwa gel, Placebo gel - HPV (Human Papillomavirus)-Associated, Genital Warts | Phase 2 | Recruiting | KTH Biopharma | 70 | 2026-07-16 | 2026-10-20 |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) VP-102 (US) / TO-208 (Japan), Vehicle (US) / Vehicle (Japan) - Common Warts, Common Warts (Verruca Vulgaris) | Phase 3 | Recruiting | Verrica Pharmaceuticals Inc. | 300 | 2026-06-15 | 2026-09-03 |
| Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts 3% hydrogen peroxide solution, 0.9 % saline, Hyperthermia at 44℃ - Warts | Not applicable | Recruiting | First Hospital of China Medical University | 210 | 2026-05-01 | 2026-04-16 |
| New Treatment of Common Wart PRF group, Vitamin D - Common Warts (Verruca Vulgaris) | Not applicable | Not yet recruiting | Sohag University | 70 | 2026-04-06 | 2026-04-22 |
| Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) Cantharidin - Common Warts (Verruca Vulgaris), Common Warts | Phase 3 | Recruiting | Verrica Pharmaceuticals Inc. | 600 | 2026-03-11 | 2026-05-05 |
| Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir Intralesional Acyclovir, Intralesional Vitamin D3 - Viral Wart, Plantar Wart | Phase 4 | Recruiting | Riphah International University | 40 | 2026-02-20 | 2026-08-07 |
| the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts. Ivermectin, microneedling, Salicylic Acid - Warts | Early Phase 1 | Not yet recruiting | Assiut University | 88 | 2026-02-01 | 2026-02-09 |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) VP-102, Vehicle - Common Warts, Common Warts (Verruca Vulgaris) | Phase 3 | Recruiting | Verrica Pharmaceuticals Inc. | 300 | 2025-12-17 | 2026-01-21 |
| Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts An infrared hyperthermia device, Hydrogen Peroxide 3 % Topical Solution, Normal Saline (NS) - Refactory Warts | Not applicable | Recruiting | First Hospital of China Medical University | 80 | 2025-10-01 | 2026-05-04 |
| Comparison of Efficacy of Topical Adaplene Gel Versus Crythotherapy in Recurrent Plantar Warts Topical Adapalene Gel 0.1%, Topical Liquid Nitrogen application - Viral Warts | Phase 4 | Recruiting | Khyber Teaching Hospital | 98 | 2025-09-15 | 2026-04-29 |
| Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts 9-valent human papillomavirus vaccine, Sterile Saline - Warts, Verruca (Warts) | Phase 2 | Active not recruiting | Rush University Medical Center | 55 | 2025-09-02 | 2026-09-15 |
| Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial. Warts | Not yet recruiting | Assiut University | 60 | 2025-07-01 | 2025-05-15 | |
| Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts Topical 25% podophyllin, Cryotherapy - Anogenital Human Papilloma Virus Infection | Phase 2 | Not yet recruiting | Sheikh Zayed Medical College | 96 | 2025-06-29 | 2025-05-13 |
| Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart Topical 5% fluorouracil cream, Topical 0.005% calcipotriol ointment, Placebo - Common Warts | Not applicable | Recruiting | Mazandaran University of Medical Sciences | 60 | 2025-05-30 | 2025-12-19 |
| Salicylic Acid Wart Patch for the Treatment of Common Warts and Plantar Warts salicylic acid wart patches - Common Warts, Plantar Warts | Not applicable | Completed | Langsteiner sp. z o.o. | 30 | 2025-05-19 | 2025-09-08 |
| A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.coli), Aluminum Adjuvant - Penile/Perineal /Perianal Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia | Phase 3 | Active not recruiting | Xiamen University | 9300 | 2025-04-11 | 2025-07-31 |
Showing 20 of 228. Sign in to see all of them.
Condylomata Acuminata (112) · Uterine Cervical Neoplasms (45) · Papillomavirus Infections (40) · Vaginal Neoplasms (18) · Vulvar Neoplasms (18) · Anus Neoplasms (9) · Sexually Transmitted Diseases (6) · Virus Diseases (6) · Skin Diseases (5) · Skin Diseases, Viral (5) · Agammaglobulinemia (4) · HIV Infections (4) · Immunologic Deficiency Syndromes (4) · Skin Diseases, Infectious (4)
Skin and Connective Tissue Diseases (228) · DNA Virus Infections (225) · Infections (225) · Tumor Virus Infections (225) · Skin Diseases, Infectious (224) · Skin Diseases (223) · Skin Diseases, Viral (223) · Virus Diseases (222) · Papillomavirus Infections (188) · Pathological Conditions, Signs and Symptoms (122) · Communicable Diseases (120) · Genital Diseases (120) · Pathologic Processes (120) · Urogenital Diseases (120) · Disease Attributes (119)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (16) · Cryotherapy (14) · Vaccines, Synthetic (10) · Papillomavirus Vaccines (7) · resiquimod (6) · Cantharidin (5) · Imiquimod (5) · PRA1 protein, Candida albicans (5) · Vaccines (5) · Gels (4) · Tuberculin (4) · VP-102 (4) · 3-ingenyl angelate (3) · Cholecalciferol (3) · Human Papillomavirus Recombinant Vaccine nonavalent (3)
Merck Sharp & Dohme LLC (20) · Assiut University (12) · Shanghai Bovax Biotechnology Co., Ltd. (12) · Graceway Pharmaceuticals, LLC (8) · Xiamen University (7) · Aclaris Therapeutics, Inc. (6) · Verrica Pharmaceuticals Inc. (6) · Zagazig University (5) · First Hospital of China Medical University (4) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Sohag University (4) · Beijing Health Guard Biotechnology, Inc (3) · Benha University (3) · Jun Zhang (3) · MediGene (3)
United States (66) · China (36) · Egypt (16) · Pakistan (6) · Argentina (5) · France (5) · Germany (5) · Canada (4) · Denmark (4) · Taiwan (4) · Belgium (3) · Chile (3) · Italy (3) · Japan (3) · Poland (3)
Jun Zhang, Master (5) · Jun Zhang, master (4) · Shichao Lu, MD (3) · Yongjiang Liu, Bachelor (3) · David H McDermott, M.D. (2) · Emmanuel B Walter, MD (2) · Feng-cai Zhu, master (2) · Gregory D Zimet, PhD (2) · Jason Wu, MD (2) · Richard Nuccitelli, PhD (2) · Scott Guenthner, MD (2) · Stuart D Shanler, MD (2) · Ting Huang (2)
PMID 32184277, PMID 41276263, PMID 19236277, PMID 19236279, PMID 19935017, PMID 27422279, PMID 30982556, PMID 41166720, PMID 15897380, PMID 20949623, PMID 21471141, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23336207, PMID 23632723, PMID 25273231, PMID 29074187, PMID 29211620, PMID 29214505, PMID 29995724, PMID 33326342, PMID 10693114, PMID 10782451, PMID 11238198, PMID 12807939, PMID 13519856, PMID 15168956, PMID 15215482, PMID 15987315, PMID 16973081, PMID 17210977, PMID 17372095, PMID 18032894, PMID 18042215, PMID 18164106, PMID 18433504, PMID 18515521, PMID 19116707, PMID 19170869, PMID 19453788, PMID 19466962, PMID 19505910, PMID 20202055, PMID 20647284, PMID 20706119, PMID 20837684, PMID 21173332, PMID 21248158, PMID 21288094
2004 (2), 2017 (1)